How often should a CO₂ (carbon dioxide) laser resurfacing be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CO₂ Laser Resurfacing Treatment Frequency

For fractional CO₂ laser resurfacing, treatments should be performed at intervals of 1 to 3 months, with most protocols using 2-4 total treatment sessions to achieve optimal results.

Treatment Interval Evidence

The most recent high-quality evidence demonstrates that treatment intervals of 1 month versus 3 months produce equivalent outcomes for fractional CO₂ laser resurfacing 1. This randomized controlled trial specifically evaluated acne scar treatment and found no significant difference in scar improvement or adverse effects between the two intervals (P = 0.81). Both intervals achieved substantial improvement in scar atrophy with similar patient satisfaction rates (P = 0.93).

Standard Treatment Protocols

Based on guideline evidence for aesthetic applications:

  • Typical course: 3-4 treatment sessions 2
  • Session spacing: Monthly intervals are most commonly used 2
  • Follow-up timing: Clinical improvements are typically assessed 3-6 months after the final treatment 2

For acne scarring specifically, studies demonstrate significant improvement after just 2 treatments, with results maintained at 6-month follow-up 1. The improvement in scar atrophy was statistically significant (P < 0.001) regardless of whether treatments were spaced 1 or 3 months apart.

Clinical Considerations for Interval Selection

Choose 1-month intervals when:

  • Patient desires faster completion of treatment course
  • Scheduling flexibility is limited
  • Downtime between sessions is acceptable

Choose 3-month intervals when:

  • Patient needs extended recovery time between sessions
  • Allowing maximal collagen remodeling between treatments
  • Managing patient expectations for gradual improvement

Important Caveats

Downtime is consistent regardless of interval: Erythema, edema, and crusting occur with both 1-month and 3-month spacing, with resolution typically within days to weeks 2. The treatment interval does not influence the severity or duration of these expected adverse effects.

Additional sessions may enhance durability: While 3-4 sessions are standard, some evidence suggests that additional treatments to further reduce follicular units may provide more lasting benefit in certain applications 3.

Combination with PRP reduces downtime: When fractional CO₂ laser is combined with platelet-rich plasma (PRP), patients experience significantly shorter duration of erythema and edema (P = 0.02), though this doesn't change the recommended treatment intervals 2.

Context-Specific Applications

For hidradenitis suppurativa treatment (a different indication), CO₂ laser protocols vary significantly, with some studies reporting 154 sessions over extended periods for surgical applications 4. However, this represents ablative/excisional use rather than resurfacing.

For post-isotretinoin patients: While traditional recommendations suggest delaying laser procedures 6-12 months after isotretinoin discontinuation, recent evidence shows careful consideration may allow earlier treatment on a case-by-case basis 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.